Paper39722012
Use of extracorporeal blood purification therapies in sepsis: the current paradigm, available evidence, and future perspectives.
Bottari G and 7 others. Crit Care, 2024. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. Use of extracorporeal blood purification therapies in sepsis: the current paradigm, available evidence, and future perspectives. Papers, record 39722012. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39722012
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Use of extracorporeal blood purification therapies in sepsis: the current paradigm, available evidence, and future perspectives.
- PubMed
Topics2
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Sepsis | Major topic |
| Humans |
Source PubMed
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 39856722 | A few words of caution on blood purification in sepsis. | https://conductscience.org/library/papers/39856722 | PubMed |
| Comment in | 40108715 | Rethinking caution: a critical appraisal of extracorporeal blood purification in sepsis. | https://conductscience.org/library/papers/40108715 | PubMed |
References89
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26903338 | The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3). | JAMA | 2016 | https://conductscience.org/library/papers/26903338 | PubMed |
| 2 | 36140361 | The End of "One Size Fits All" Sepsis Therapies: Toward an Individualized Approach. | Biomedicines | 2022 | https://conductscience.org/library/papers/36140361 | PubMed |
| 3 | 36012544 | Pathophysiology of Sepsis and Genesis of Septic Shock: The Critical Role of Mesenchymal Stem Cells (MSCs). | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/36012544 | PubMed |
| 4 | 22616830 | Drotrecogin alfa (activated) in adults with septic shock. | N Engl J Med | 2012 | https://conductscience.org/library/papers/22616830 | PubMed |
| 5 | 7884952 | Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome. A randomized, controlled, double-blind, multicenter clinical trial. TNF-alpha MAb Sepsis Study Group. | JAMA | 1995 | https://conductscience.org/library/papers/7884952 | PubMed |
| 6 | 9233735 | Confirmatory interleukin-1 receptor antagonist trial in severe sepsis: a phase III, randomized, double-blind, placebo-controlled, multicenter trial. The Interleukin-1 Receptor Antagonist Sepsis Investigator Group. | Crit Care Med | 1997 | https://conductscience.org/library/papers/9233735 | PubMed |
| 7 | 16263005 | Reprogramming of circulatory cells in sepsis and SIRS. | J Endotoxin Res | 2005 | https://conductscience.org/library/papers/16263005 | PubMed |
| 8 | 12072677 | A pilot study of coupled plasma filtration with adsorption in septic shock. | Crit Care Med | 2002 | https://conductscience.org/library/papers/12072677 | PubMed |
| 9 | 37034019 | Extracorporeal blood purification strategies in sepsis and septic shock: An insight into recent advancements. | World J Crit Care Med | 2023 | https://conductscience.org/library/papers/37034019 | PubMed |
| 10 | 34638575 | Renal Replacement Techniques in Septic Shock. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/34638575 | PubMed |
| 11 | 12940901 | Interpreting the mechanisms of continuous renal replacement therapy in sepsis: the peak concentration hypothesis. | Artif Organs | 2003 | https://conductscience.org/library/papers/12940901 | PubMed |
| 12 | 12296458 | Acute renal failure and multiple organ dysfunction in the ICU: from renal replacement therapy (RRT) to multiple organ support therapy (MOST). | Int J Artif Organs | 2002 | https://conductscience.org/library/papers/12296458 | PubMed |
| 13 | 29597227 | From Continuous Renal Replacement Therapies to Multiple Organ Support Therapy. | Contrib Nephrol | 2018 | https://conductscience.org/library/papers/29597227 | PubMed |
| 14 | 28973628 | Extracorporeal Organ Support: From Technological Tool to Clinical Strategy Supporting Severe Organ Failure. | JAMA | 2017 | https://conductscience.org/library/papers/28973628 | PubMed |
| 15 | 30043276 | Extracorporeal organ support (ECOS) in critical illness and acute kidney injury: from native to artificial organ crosstalk. | Intensive Care Med | 2018 | https://conductscience.org/library/papers/30043276 | PubMed |
| 16 | 16137340 | Pulse high-volume haemofiltration for treatment of severe sepsis: effects on hemodynamics and survival. | Crit Care | 2005 | https://conductscience.org/library/papers/16137340 | PubMed |
| 17 | 22673249 | Effectiveness of short-term 6-hour high-volume hemofiltration during refractory severe septic shock. | J Trauma Acute Care Surg | 2012 | https://conductscience.org/library/papers/22673249 | PubMed |
| 18 | 23740278 | High-volume versus standard-volume haemofiltration for septic shock patients with acute kidney injury (IVOIRE study): a multicentre randomized controlled trial. | Intensive Care Med | 2013 | https://conductscience.org/library/papers/23740278 | PubMed |
| 19 | 24292260 | High-volume hemofiltration in critically ill patients: a systematic review and meta-analysis. | Minerva Anestesiol | 2014 | https://conductscience.org/library/papers/24292260 | PubMed |
| 20 | 18828196 | Intensive plasma exchange increases a disintegrin and metalloprotease with thrombospondin motifs-13 activity and reverses organ dysfunction in children with thrombocytopenia-associated multiple organ failure. | Crit Care Med | 2008 | https://conductscience.org/library/papers/18828196 | PubMed |
Cited by36
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42979081 | Hemodynamic response to high-volume hemofiltration in pediatric septic shock. | J Intensive Med | 2026 | https://conductscience.org/library/papers/42979081 | PubMed |
| 42920688 | Extracorporeal kidney support in neonates and infants: therapeutic perspectives and outcomes in multiple organ dysfunction syndrome-a structured narrative review. | Front Pediatr | 2026 | https://conductscience.org/library/papers/42920688 | PubMed |
| 42882032 | Ventilator-Associated Pneumonia: The Role of Kidney-Lung Crosstalk and Renal Replacement Therapy, a Narrative Review. | J Clin Med | 2026 | https://conductscience.org/library/papers/42882032 | PubMed |
| 42814147 | An interpretable machine learning model for early prediction of subsequent observed CRRT initiation in patients with sepsis-associated acute kidney injury. | Clin Exp Med | 2026 | https://conductscience.org/library/papers/42814147 | PubMed |
| 42769164 | Continuous blood purification technology for treatment of critically ill patients with chronic renal failure. | Am J Transl Res | 2026 | https://conductscience.org/library/papers/42769164 | PubMed |
| 42688080 | Effect of anakinra on cytokine storm during sepsis-induced multiple organ dysfunction syndrome: case report and preclinical investigation. | Front Immunol | 2026 | https://conductscience.org/library/papers/42688080 | PubMed |
| 42583650 | Beneficial effects of PMX-DHP on vasopressor-resistant invasive meningococcal disease: a case report. | Ann Med Surg (Lond) | 2026 | https://conductscience.org/library/papers/42583650 | PubMed |
| 42509986 | Hemoadsorptionin Critically Ill Pediatric Oncology and Hemato-Oncology Patients: A Systematic Review with Structured Narrative Synthesis. | Children (Basel) | 2026 | https://conductscience.org/library/papers/42509986 | PubMed |
| 42463127 | Effects on mortality of different blood purification techniques in sepsis patients: an umbrella review of systematic reviews and meta-analyses. | Ren Fail | 2026 | https://conductscience.org/library/papers/42463127 | PubMed |
| 42396239 | Clinical applications of oXiris membranes: Targeting inflammation and renal dysfunction in ICU patients. | J Intensive Med | 2026 | https://conductscience.org/library/papers/42396239 | PubMed |
| 42396235 | Impact of different extracorporeal blood purification strategies during continuous renal replacement therapy in septic shock patients. | J Intensive Med | 2026 | https://conductscience.org/library/papers/42396235 | PubMed |
| 42378236 | Early start of hemoadsorption is associated with improved kidney recovery in ICU patients with ischemic/reperfusion cause of rhabdomyolysis. | PLoS One | 2026 | https://conductscience.org/library/papers/42378236 | PubMed |
| 42329335 | Exploratory dose modeling of hemoadsorption in pediatric septic shock. | Intensive Care Med Exp | 2026 | https://conductscience.org/library/papers/42329335 | PubMed |
| 42195132 | Assessment of the Microcirculation During Extracorporeal Blood Purification in Septic Patients: A Narrative Review. | Medicina (Kaunas) | 2026 | https://conductscience.org/library/papers/42195132 | PubMed |
| 42164582 | Cytokine storm in acute respiratory distress syndrome. | J Intensive Med | 2026 | https://conductscience.org/library/papers/42164582 | PubMed |
| 42140195 | Artificial exosomes synergistically reshape sepsis immune homeostasis by modulating neutrophil fate and blocking PD-1/PD-L1. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/42140195 | PubMed |
| 42121061 | Hematological parameter dynamics in critically ill patients treated with oXiris®-based CRRT and CytoSorb® hemoadsorption: a prospective single-center study. | BMC Nephrol | 2026 | https://conductscience.org/library/papers/42121061 | PubMed |
| 41835642 | Continuous Renal Replacement Therapy for Patients With Sepsis in a Low-Resource Medical Intensive Care Unit (MICU): Incidence, Risk Factors, and Outcomes. | Cureus | 2026 | https://conductscience.org/library/papers/41835642 | PubMed |
| 41814716 | Exploring the mechanism of polymorphonuclear neutrophils against sepsis based on immune model. | Ann Med | 2026 | https://conductscience.org/library/papers/41814716 | PubMed |
| 41809148 | Integrating serum ferritin and neutrophil-to-lymphocyte ratio with Sequential Organ Failure Assessment score improves mortality prediction in sepsis. | World J Methodol | 2026 | https://conductscience.org/library/papers/41809148 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39722012
GET https://conductscience.org/api/papers/v1/39722012/references?page=2